Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia
- PMID: 11698298
- DOI: 10.1182/blood.v98.10.3113
Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia
Abstract
Human erythrocyte pyruvate kinase plays an important role in erythrocyte metabolism. Mutation on the gene results in pyruvate kinase deficiency and is an important cause of hereditary nonspherocytic hemolytic anemia. Because of difficulties in isolating the mutant enzymes from patients, these mutations have not been fully studied. In this study, a complementary DNA (cDNA) encoding the human erythrocyte pyruvate kinase was generated. The cDNA was cloned into several expression vectors, and the protein was expressed and purified. The tetrameric protein exhibited properties characteristic of authentic human erythrocyte pyruvate kinase, including response to substrate, phosphoenolpyruvate, activation by fructose 1,6-bisphosphate, and inhibition by adenosine triphosphate (ATP). The N-terminal segment of the protein was highly susceptible to proteolysis, but only 2 of the 4 subunits were cleaved and lacked 47 N-terminal amino acid residues. A mutant protein, R510Q, which is the most frequently occurring mutation among Northern European population, was also generated and purified. The mutant protein retained its binding capacity to and could be activated by fructose 1,6-bisphosphate and showed similar kinetics toward phosphoenolpyruvate and adenosine diphosphate as for the wild-type enzyme. Conversely, the mutant protein has a dramatically decreased stability toward heat and is more susceptible to ATP inhibition. The enzyme instability decreases the enzyme level in the cell, accounting for the clinically observed "pyruvate kinase deficiency" of patients who are homozygous for this mutation. This study provides the first detailed functional characterization of human erythrocyte pyruvate kinase. These findings will allow the establishment of a fine correlation between molecular abnormalities and the clinical expression of the disease.
Similar articles
-
Primary structure of murine red blood cell-type pyruvate kinase (PK) and molecular characterization of PK deficiency identified in the CBA strain.Blood. 1995 Oct 15;86(8):3205-10. Blood. 1995. PMID: 7579416
-
Biochemical characterization of three mutant isozymes of erythrocyte pyruvate kinase: PK-"Gainesville," PK-"San Juan," and PK-"Cape Canaveral".Am J Hematol. 1983 Jun;14(4):335-44. doi: 10.1002/ajh.2830140404. Am J Hematol. 1983. PMID: 6859032
-
[Significance of kinetic abnormalities of erythrocyte pyruvate kinase in congenital deficiencies].Pathol Biol (Paris). 1977 Mar;25(3):161-7. Pathol Biol (Paris). 1977. PMID: 323784 French.
-
Hematologically important mutations: red cell pyruvate kinase (2nd update).Blood Cells Mol Dis. 1998 Sep;24(3):273-9. doi: 10.1006/bcmd.1998.0193. Blood Cells Mol Dis. 1998. PMID: 10087985 Review. No abstract available.
-
Red cell pyruvate kinase deficiency: from genetics to clinical manifestations.Baillieres Best Pract Res Clin Haematol. 2000 Mar;13(1):57-81. doi: 10.1053/beha.1999.0057. Baillieres Best Pract Res Clin Haematol. 2000. PMID: 10916678 Review.
Cited by
-
Structures of pyruvate kinases display evolutionarily divergent allosteric strategies.R Soc Open Sci. 2014 Sep 24;1(1):140120. doi: 10.1098/rsos.140120. eCollection 2014 Sep. R Soc Open Sci. 2014. PMID: 26064527 Free PMC article.
-
Molecular heterogeneity of pyruvate kinase deficiency.Haematologica. 2020 Sep 1;105(9):2218-2228. doi: 10.3324/haematol.2019.241141. Haematologica. 2020. PMID: 33054047 Free PMC article. Review.
-
The pH dependence of the allosteric response of human liver pyruvate kinase to fructose-1,6-bisphosphate, ATP, and alanine.Arch Biochem Biophys. 2009 Apr 1;484(1):16-23. doi: 10.1016/j.abb.2009.01.011. Epub 2009 Jan 20. Arch Biochem Biophys. 2009. PMID: 19467627 Free PMC article.
-
Updates and advances in pyruvate kinase deficiency.Trends Mol Med. 2023 May;29(5):406-418. doi: 10.1016/j.molmed.2023.02.005. Epub 2023 Mar 17. Trends Mol Med. 2023. PMID: 36935283 Free PMC article. Review.
-
Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.Antimicrob Agents Chemother. 2011 May;55(5):2042-53. doi: 10.1128/AAC.01250-10. Epub 2011 Feb 28. Antimicrob Agents Chemother. 2011. PMID: 21357306 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases